Cargando…
Biomimetic nanomedicines for precise atherosclerosis theranostics
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-ba...
Autores principales: | Tao, Ying, Lan, Xinmiao, Zhang, Yang, Fu, Chenxing, Liu, Lu, Cao, Feng, Guo, Weisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638499/ https://www.ncbi.nlm.nih.gov/pubmed/37969739 http://dx.doi.org/10.1016/j.apsb.2022.11.014 |
Ejemplares similares
-
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
por: Xu, Xiao, et al.
Publicado: (2023) -
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
por: Tuguntaev, Ruslan G., et al.
Publicado: (2022) -
Theranostic nanomedicine for cancer detection and treatment
por: Fan, Zhen, et al.
Publicado: (2014) -
Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching
por: Ma, Sai, et al.
Publicado: (2018) -
Stimuli-activatable nanomedicine meets cancer theranostics
por: Li, Haonan, et al.
Publicado: (2023)